Skip to main content
Clinical Trials/NCT05717907
NCT05717907CompletedNot Applicable

Suction Catheter as a Guide for Nasotracheal Intubation Under General Anesthesia: Randomized Clinical Trial of Efficacy

Mahidol University2 sites in 1 country52 target enrollmentStarted: September 5, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
2
Primary Endpoint
Extent of Bleeding

Study Overview

Brief Summary

The goal of this clinical trial to study the efficacy of suction catheter guided technique and conventional technique during nasotracheal intubation.

The main question are

  • How effective of the use of a suction catheter guided ETT in reducing bleeding during nasotracheal intubation?
  • Does the use of a suction catheter guided ETT can improve its navigability through the nasal passage and reduce nasal passage time?

Detailed Description

Study design Clinical trial: Prospective randomized controlled trial with equal randomization (1:1), double-blinded (Participant and Primary outcome assessor), parallel design

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient undergoing elective oral and maxillofacial surgery in which nasotracheal intubation is preferred over orotracheal intubation to optimize surgical access.
  • ASA physical status I-II
  • Thai adult, aged 18-65 years old
  • Normal Body Mass Index (BMI = 18.5-24.9)

Exclusion Criteria

  • Anticipated difficult airway (e.g., Mallampati classification 3-4, interincisal distance < 35 mm., thyromental length < 60 mm., limited neck mobility)
  • Nasal infection or systemic infection
  • Abnormal coagulation status or having bleeding disorder or taking anticoagulation/antiplatelet medication
  • History of recurrent epistaxis since adulthood
  • Allergic rhinitis that necessitates the use of glucocorticoids, antihistamine, antileukotriene or decongestant in the past 4 weeks
  • History of nasal trauma or abnormality (e.g., trauma in mid-face region, nasal surgery, nasal polyps, chronic sinusitis, abnormal nasal vasculature, tumor in nasal region, radiotherapy in nasal region)
  • Craniofacial deformity syndrome
  • Using nasal oxygen or Continuous Positive Airway Pressure (CPAP)
  • Previous nasotracheal intubation or nasogastric tube placement within 3 months
  • Diagnosed as having a mental disorder
  • Drop-out criteria:
  • Unable to complete intubation procedure
  • Intubation failed on both nostrils
  • When intubation was only possible with a tube smaller than 6.5 internal diameter (ID) in male and 6.0 ID in female
  • Inadequate data collection

Outcomes

Primary Outcomes

Extent of Bleeding

Time Frame: measured from video recorded at insert to withdraw videolaryngoscope

The video from video laryngoscope will be recorded at the moment during and immediately after successful intubation, which will be later reviewed by primary outcome assessor that not involved in the procedure. Accounting for only bleeding observed at posterior pharyngeal area, which originate from trauma from attempt to pass ETT through the nasal passage into the pharynx. Assessment of bleeding will be scored at the most severe bleeding state observed from inserting to the removal of video laryngoscope after successful intubation. The extent of bleeding will be graded as: "Grade 0" = no bleeding "Grade 1" = blood-stained tube and/or cuff "Grade 2" = blood-stained posterior pharyngeal wall (traces or streak of blood) "Grade 3" = blood pooling at posterior pharyngeal wall

Incidence of Bleeding

Time Frame: measured immediately after successful intubation

rate of incidence of bleeding * No Bleeding (Grade 0) * Bleeding (Grade 1, 2, 3)

Secondary Outcomes

  • Ease of Navigation(measured immediately after successful intubation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Duangdee Rummasak

Assoc. Prof.

Mahidol University

Study Sites (2)

Loading locations...

Similar Trials